10mg tirzepatide compound UK 2026 Buy Tirzepatide 10mg (GLP-1/GIP) |

23431, with a comment deadline extended to July 30, 2026 by 91 Fed

Real-World Evidence: A retrospective cohort study using electronic health record data found that tirzepatide was associated with a mean weight loss of 6.6 kg compared to 3.1 kg for semaglutide over a 6-month follow-up period

Patients were further required to have 1 record of clinical activity during the 6 months after index (follow-up) and in each consecutive 6-month period of baseline, and 1 record of weight and/or BMI within 60 days prior to index and 30 days before or after the end of the 6-month follow-up period

Active malignancy, pregnancy, lactation, uncontrolled diabetes, history of pituitary tumors, and individuals under 25 are contraindications

Ne alkalmazza ezt a gygyszert, ha az oldat nem tiszta vagy nem szntelen, illetve nem majdnem szntelen